Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.7438
Delayed Data
As of Apr 17
 -0.0212 / -2.77%
Today’s Change
0.65
Today|||52-Week Range
1.08
+6.26%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close0.77
Today’s open0.77
Day’s range0.74 - 0.77
Volume418,085
Average volume (3 months)575,751
Market cap$137.1M
Dividend yield--
Data as of 4:00pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)-57.14%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book--

Competitors

 Today’s
change
Today’s
% change
--Ecogreen Fine Chemic...+0.00+0.72%
ARQLArQule Inc-0.03-1.38%
MDWDMediwound Ltd+0.08+1.27%
BLPHBellerophon Therapeu...-0.18-1.71%
Data as of 3:59pm ET, 04/17/2015

Financials

Next reporting dateMay 14, 2015
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$0.00
Annual profit (last year)-$18.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Scientist
Chang Ho Ahn
Chief Executive Officer &
Director
Peter David Suzdak
Corporate headquarters
Rockville, Maryland

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers